Skip to main content

Month: March 2026

Aurora Mobile Issues Letter to Shareholders

SHENZHEN, China, March 12, 2026 (GLOBE NEWSWIRE) — Aurora Mobile (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today issued a letter to shareholders from its Chairman and Chief Executive Officer, Mr. Weidong Luo. Dear Shareholders, First, I would like to sincerely thank all of our shareholders for your continued trust and support. The year 2025 marked a milestone for Aurora Mobile. For the first time in our history, we achieved full-year profitability on a GAAP basis. This milestone represents more than a change in financial results. It signals that our business model, product capabilities, organizational efficiency, and strategies for globalization and technology are beginning to yield tangible returns. More importantly, this result was not a one-time...

Continue reading

Gogoro Announces US$16.7 Million New Equity Investment From Gold Sino

TAIPEI, Taiwan, March 12, 2026 (GLOBE NEWSWIRE) — Gogoro Inc. (“Gogoro,” “the Company” or “We”) (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced that it has entered into a Share Purchase Agreement (the “SPA”) with Gold Sino Assets Limited (“Gold Sino”) on March 11, 2026, the Company’s largest shareholder that holds 31.4% of the Company’s total outstanding shares, pursuant to which Gold Sino agreed to make a new equity investment (the “New Equity Investment”) in the amount of approximately US$16.7 million in the Company. The SPA was approved by the audit committee and board of directors of the Company. The New Equity Investment will be the first equity investment secured by Mr. Yin Chung Yao, a director of the Company and an affiliate of...

Continue reading

Lahontan Announces Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 12, 2026 (GLOBE NEWSWIRE) — Lahontan Gold Corp. (TSXV:LG, OTCQB:LGCXF, FSE:Y2F) (the “Company” or “Lahontan“) is pleased to announce that it intends to complete a non-brokered private placement of up to 24,390,244 units (each, a “Unit“) in the capital of the Company at a price of Cdn $0.41 per Unit for gross proceeds of up to Cdn $10,000,000 (the “Offering“). Each Unit shall be comprised of one common share (each, a “Common Share“) in the capital of the Company and one-half of one whole Common Share purchase warrant (each whole warrant, a “Warrant“). Each Warrant entitles the holder thereof to purchase one Common Share at a price of Cdn $0.60 per...

Continue reading

Bimergen Energy to Present its $2B Growth Strategy at the LD Micro 16th Annual Invitational

Newport Beach, CA, March 12, 2026 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy storage systems (BESS) across the United States, today announced that the Company will participate in the LD Micro 16th Annual Invitational, taking place May 17-19 , 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Bimergen’s Co-CEO, Bob Brilon, will deliver a corporate presentation and conduct one-on-one meetings with investors during the conference. Details regarding the Company’s presentation time will be announced in May. The LD Micro Invitational is one of the premier investor conferences focused on microcap companies, bringing together leading institutional investors and emerging growth companies for presentations...

Continue reading

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

New clinical data from the SYMON-I study to evaluate IL-6 and organ dysfunction in sepsis patients to be presented. ACTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient tests for critical care conditions, today announced that an abstract related to its Symphony™ IL-6 Test has been accepted for presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting, which will take place May 18–21, 2026 in Atlanta, Georgia. The presentation will report findings from SYMON-I, a multicenter pilot clinical study evaluating interleukin-6 (IL-6) levels in patients with sepsis who were admitted or intended for admission to the intensive care unit (ICU). The analysis evaluates the relationship...

Continue reading

Vivid Seats Reports Fourth Quarter and Full Year 2025 Results

Provides Q1 Guidance and Reaffirms 2026 Outlook Driven by Leading Value Proposition and Efficiency Initiatives CHICAGO, March 12, 2026 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the fourth quarter and full year ended December 31, 2025 along with guidance for the first quarter ending March 31, 2026 and full year ending December 31, 2026. “The trends we are seeing in the first quarter confirm that our strategy and execution are delivering measurable results,” said Lawrence Fey, Chief Executive Officer of Vivid Seats. “We are enhancing our foundational strengths that include our leading technology,...

Continue reading

Aurora Mobile Limited Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

SHENZHEN, China, March 12, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. Weidong Luo, Chairman and Chief Executive Officer of Aurora Mobile, commented, “2025 marks the first time in our history that we recorded full-year net profit on a GAAP basis! In addition, we delivered an incredible fourth quarter of 2025 where:Total revenue surpassed the RMB100 million mark to reach RMB105.2 million, representing a remarkable 13% year-over-year and 16% sequential increase and exceeding the guidance we issued last quarter. Our global flagship product, EngageLab, accelerated its growth trajectory as it...

Continue reading

Form 8.3 – [AUGMENTUM FINTECH PLC – 11 03 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree AUGMENTUM FINTECH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/a(e)   Date position...

Continue reading

Aclarion CEO Brent Ness to Attend LSI USA 2026

BROOMFIELD, Colo., March 12, 2026 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that Brent Ness, Chief Executive Officer, will be attending LSI USA 2026, one of the leading conferences of global MedTech innovators, investors, and industry leaders. During the event, Mr. Ness will meet with investors and potential industry partners to discuss Aclarion’s continued progress advancing NOCISCAN, the company’s proprietary MR spectroscopy platform that leverages AI and biomarkers to help physicians distinguish between painful and non-painful discs in patients suffering from chronic...

Continue reading

KBR Wins General Maintenance Services Contract from SATORP for its Strategic Petrochemical Expansion Complex

HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) announced today it has been awarded a landmark seven-year General Maintenance Services (GMS) contract, with an optional three-year extension, from Saudi Aramco Total Refining and Petrochemical Company (SATORP) for its strategic petrochemical expansion complex in Jubail, Kingdom of Saudi Arabia. Under the agreement, KBR will deliver a comprehensive suite of preventive, predictive, corrective, and shutdown maintenance services designed to achieve exceptional performance and reliability across the entire petrochemical complex. Building on more than a decade of trusted collaboration with SATORP, KBR will leverage its proven expertise and practices to support industry-leading commissioning and start-up, with the intent of achieving peak availability and reliability from day one...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.